Evidence map›Paper›PMID 28785378›Full record

ArticleOxidative medicine and cellular longevity2017

Progression of Hepatic Adenoma to Carcinoma in

Anna Kakehashi, Naomi Ishii, Takahiro Okuno, Masaki Fujioka, Min Gi, Shoji Fukushima, Hideki Wanibuchi

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. TrxR1, Gsr, and oxidative stress determine hepatocellular carcinoma malignancy.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  4. Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis.International journal of molecular sciences · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna KakehashiDepartment of Molecular Pathology, Osaka City University Graduate School of Medicine, Abeno-Ku, Asahi-Machi 1-4-3, Osaka 545-8585, Japan.ORCID 0000-0003-1149-1450
Naomi IshiiDepartment of Molecular Pathology, Osaka City University Graduate School of Medicine, Abeno-Ku, Asahi-Machi 1-4-3, Osaka 545-8585, Japan.
Takahiro OkunoDepartment of Molecular Pathology, Osaka City University Graduate School of Medicine, Abeno-Ku, Asahi-Machi 1-4-3, Osaka 545-8585, Japan.
Masaki FujiokaDepartment of Molecular Pathology, Osaka City University Graduate School of Medicine, Abeno-Ku, Asahi-Machi 1-4-3, Osaka 545-8585, Japan.
Min GiDepartment of Molecular Pathology, Osaka City University Graduate School of Medicine, Abeno-Ku, Asahi-Machi 1-4-3, Osaka 545-8585, Japan.ORCID 0000-0003-1642-8127
Shoji FukushimaDepartment of Molecular Pathology, Osaka City University Graduate School of Medicine, Abeno-Ku, Asahi-Machi 1-4-3, Osaka 545-8585, Japan.
Hideki WanibuchiDepartment of Molecular Pathology, Osaka City University Graduate School of Medicine, Abeno-Ku, Asahi-Machi 1-4-3, Osaka 545-8585, Japan.
Osaka City University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The carcinogenic potential of phenobarbital (PB) was assessed in a mouse line carrying a mutant

Indexed as

Disease Progression8-Hydroxy-2'-DeoxyguanosineAdenomaAnimalsApoptosisCell ProliferationDeoxyguanosineDNA GlycosylasesFemaleImmunohistochemistryLiver NeoplasmsMaleMice, Inbred C57BLMice, Mutant StrainsModels, BiologicalNF-E2-Related Factor 28-Hydroxy-2'-DeoxyguanosineDeoxyguanosineDNA GlycosylasesNfe2l2 protein, mouseNF-E2-Related Factor 2Ogg1 protein, mousePhenobarbital

Identifiers

PMID28785378
PMCPMC5530452
OpenAlexW2734452247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.